← Leaderboards
Stephanie Priscilla Vega
Fannin Partners, Llc
$1,136,119
Attributed
$2,272,238
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2021–22$2M$1.5M$1M$500K$0
'21
'22
Funding mix
By agency
NIH$2,272,238 · 2
By mechanism
R44$1,972,317 · 1
R43$299,921 · 1
Top collaborators
- Atul Varadhachary3 shared
Others in their field
Other Emerging Leaders on “Cost”
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Scott Topper · Broad Institute, Inc.$77,958,806
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Mark Marino · Venturewell$48,913,644
- John Damon Chodera · Sloan-Kettering Inst Can Research$48,367,817
- Leonard Freedman · Leidos Biomedical Research, Inc.$41,527,040
Research focus
CostEnzymesProteinsTissuesModificationCombinatorialLibrariesOligonucleotidesSerumAffinityBaseNovel StrategiesAptamerC-Type LectinsDisabilityAntiveninsCreatine KinaseCrotalusDissociationCessation Of LifeBindingCopperheadsAntibodiesComplex Mixtures
Grant awards (3)
Aptamer therapeutic for safe and low-cost treatment of snake bite envenomation$978,343
R44 · FY2022 · OD · contact PI
Expediting the Biomarker Discovery Process Through a Novel Bead-Based Aptamer Capture Platform$299,921
R43 · FY2022 · GM · contact PI
Aptamer therapeutic for safe and low-cost treatment of snake bite envenomation$993,974
R44 · FY2021 · OD · contact PI